Ambryon Biosciences

AAV8BP2 Serotype

Bioprocessing-optimized AAV8 variant engineered for enhanced manufacturability with improved thermal stability and production yields.

TropismLiver, muscle, CNS (identical to AAV8)

Characteristics

Improved thermal stability. Higher production yields in manufacturing. Maintained wild-type AAV8 tropism profile. Enhanced scalability for clinical production. Favorable bioprocessing characteristics.

Applications

Clinical-scale liver gene therapy. Hemophilia gene therapy with improved manufacturing. Large-scale AAV production applications.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Markusic et al. (2010). High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines. Mol Ther — Markusic 2010 AAV8BP2

Identifiers & revision